Elizabeth Yeu Lin net worth and biography

Elizabeth Lin Biography and Net Worth

Director of STAAR Surgical

Dr. Yeu has been a Partner at Virginia Eye Consultants since 2014. She has served as an Assistant Professor of Ophthalmology at the Eastern Virginia Medical School since 2012. Dr. Yeu was President of the American Society of Cataract and Refractive Surgery (ASCRS) from 2023 to 2024, and serves on the ASCRS Executive Board. Dr. Yeu has authored hundreds of medical journal articles and is a frequent lecturer nationally and internationally in the areas of refractive cataract surgery, anterior segment reconstruction, ocular surface disease management and the surgical management of astigmatism. Dr. Yeu was voted to The Ophthalmologist's Power List as follows: Global Top 100 Power List 2022 and 2020, Top 100 Women in Ophthalmology in 2021, Emerging Leader in 2019, Rising Stars in 2017 and Top 40 Under 40 in 2015. Dr. Yeu received the Women in Medicine’s Top Ophthalmologist Award in 2021, the inaugural Clinical Rising Star award in 2018 by the Ophthalmic Innovations Summit (OIS), was recognized as a Castle Connelly Top Doc 2016-2022 and received their Exceptional Women in Medicine Award in 2017-2018, earned the Best Doctors Award by her peers from 2013-2016, the Millennial Eye Award in 2015, and was recognized as Top 40 Under 40 through Virginia’s Inside Business Journal. Since December 2021, Dr. Yeu has served on the board of directors of Tarsus Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address a prevalent disease with limited treatment options. Since November 2024, she has served as Chief Medical Officer of Tarsus.

Dr. Yeu earned her medical degree through an accelerated and combined undergraduate/medical school program at the University of Florida College of Medicine. She completed her Ophthalmology residency at Rush University Medical Center in Chicago, where she served as Chief Resident (2006-2007). Dr. Yeu completed a fellowship in cornea, anterior segment, and refractive surgery at Baylor College of Medicine’s Cullen Eye Institute from 2007-2008, and she served as an Assistant Professor after her fellowship training.

What is Elizabeth Yeu Lin's net worth?: The estimated net worth of Elizabeth Yeu Lin is at least $46,079.70 as of September 21st, 2023. Dr. Lin owns 2,855 shares of STAAR Surgical stock worth more than $46,080 as of April 17th. This net worth estimate does not reflect any other investments that Dr. Lin may own. Learn More about Elizabeth Yeu Lin's net worth.
How do I contact Elizabeth Yeu Lin?: The corporate mailing address for Dr. Lin and other STAAR Surgical executives is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. STAAR Surgical can also be reached via phone at (626) 303-7902 and via email at bmoore@staar.com. Learn More on Elizabeth Yeu Lin's contact information.
Has Elizabeth Yeu Lin been buying or selling shares of STAAR Surgical?: Elizabeth Yeu Lin has not been actively trading shares of STAAR Surgical within the last three months. Most recently, on Thursday, September 21st, Elizabeth Yeu Lin bought 2,500 shares of STAAR Surgical stock. The stock was acquired at an average cost of $40.00 per share, with a total value of $100,000.00. Following the completion of the transaction, the director now directly owns 2,855 shares of the company's stock, valued at $114,200. Learn More on Elizabeth Yeu Lin's trading history.
Who are STAAR Surgical's active insiders?: STAAR Surgical's insider roster includes Hans-Martin Blickensdoerfer (VP), Arthur Butcher (Director), James Francese (VP), Samuel Gesten (Insider), Graydon Hansen (VP), Jon Hayashida (VP), Keith Holliday (CTO), Elizabeth Lin (Director), Caren Mason (CEO), Aimee Weisner (Director), and Patrick Williams (CFO). Learn More on STAAR Surgical's active insiders.
Are insiders buying or selling shares of STAAR Surgical?: During the last twelve months, STAAR Surgical insiders bought shares 19 times. They purchased a total of 1,849,773 shares worth more than $30,944,710.46. The most recent insider tranaction occured on April, 9th when Major Shareholder Broadwood Partners, L.P. bought 8,200 shares worth more than $123,656.00. Insiders at STAAR Surgical own 1.0% of the company. Learn More about insider trades at STAAR Surgical.
Information on this page was last updated on 4/9/2025.

Elizabeth Yeu Lin Insider Trading History at STAAR Surgical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/21/2023	Buy	2,500	$40.00	$100,000.00	2,855

Elizabeth Yeu Lin Buying and Selling Activity at STAAR Surgical

STAAR Surgical Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Today's Range

Now: $16.14

$15.97

$16.72

50 Day Range

MA: $17.29

$15.09

$22.61

2 Week Range

Now: $16.14

$13.50

$49.86

Volume

636,463 shs

Average Volume

787,352 shs

Market Capitalization

$796.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75